Concepedia

Joanna Long

JL

Statistics

Publications

4

Citations

810

H-Index

4

Active since

2002

Affiliations

Vertex Pharmaceuticals (United Kingdom)(Current)

Vertex Pharmaceuticals (United States)

Joanna Long is an author at Vertex Pharmaceuticals (United Kingdom) specializing in life sciences, molecular biology, and protein kinase cascades.

Publications per year

2002–2011

4

Publications

4

Selective killing of ATM- or p53-deficient cancer cells through inhibition of ATR

Philip M. Reaper, Matthew R. Griffiths, Joanna Long et al. · Nature Chemical Biology · 2011 · 639 citations

, , +14

Structural Basis for the Interaction of TAK1 Kinase with its Activating Protein TAB1

Kieron Brown, Sarah Vial, Neesha Dedi et al. · Journal of Molecular Biology · 2005 · 93 citations

, , +8

Crystal Structures of Interleukin-2 Tyrosine Kinase and Their Implications for the Design of Selective Inhibitors

Kieron Brown, Joanna Long, Sarah Vial et al. · Journal of Biological Chemistry · 2004 · 62 citations · Full text

, , +13

Protection of hDAF‐transgenic porcine endothelial cells against activation by human complement: role of the membrane attack complex

Wolfgang Fecke, Joanna Long, Andrew Richards et al. · Xenotransplantation · 2002 · 16 citations

, , +17

1–4 of 4